Aquestive Therapeutics Executives Sell Shares for $4.17 Each on March 10, 2026.
ByAinvest
Wednesday, Mar 11, 2026 12:55 pm ET1min read
AQST--
Aquestive Therapeutics, Inc. (AQST) announced that President and CEO Daniel Barber sold 180,677 shares at $4.17/share on March 10, 2026. In addition, Chief People Officer Peter E. Boyd sold 29,814 shares at $4.17/share, Chief Legal Officer Lori J. Braender sold 40,102 shares at $4.17/share, SVP, Regulatory Affairs Melina Cioffi sold 25,311 shares at $4.17/share, Chief Operating Officer Cassie Jung sold 45,791 shares at $4.17/share, and Chief Commercial Officer Sherry Korczynski sold 15,741 shares at $4.17/share. Furthermore, Chief Financial Officer Ernest Toth Jr. sold 58,254 shares at $4.17/share.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet